<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01449370</url>
  </required_header>
  <id_info>
    <org_study_id>INK1117-001</org_study_id>
    <nct_id>NCT01449370</nct_id>
  </id_info>
  <brief_title>Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer</brief_title>
  <official_title>A Phase I, Dose Escalation Study of MLN1117 in Subjects With Advanced Solid Malignancies Followed by Expansion in Subjects With Measurable Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Millennium Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Takeda</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the maximum tolerated dose (MTD) and/or optimal
      biologic dose(OBD), safety and tolerability, dose-limiting toxicity (DLT) of TAK-117 when
      administered orally in subjects with advanced solid malignancies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum Tolerated Dose (MTD) of TAK-117</measure>
    <time_frame>Baseline up to Cycle 1 Day 21</time_frame>
    <description>MTD is highest dose level of TAK-117 at which no more than 1 out of 6 participants had a dose limiting toxicity (DLT) during first cycle. DLT was any 1 of following events occurring within first 21 days of Cycle 1 of TAK-117 administration, Grade 2: fasting hyperglycemia for &gt;14 days. Grade 3: nausea and/or vomiting/diarrhea for &gt;7 days; rash for &gt;7 days; thrombocytopenia with bleeding; fasting hyperglycemia for &gt;24 hours(hr). Grade &gt;=3:nonhematologic toxicity considered clinically significant by investigator. Grade 4:neutropenia (absolute neutrophil count &lt;=0.5*10^9per liter[/L]) for &gt;7 days in absence of growth factor support; neutropenia of any duration accompanied with fever &gt;=38.5 degree Celsius and/or systemic infection. Grade &gt;=4:hematologic toxicity. Inability to administer at least 75% of planned doses of TAK-117 within Cycle 1 due to its related toxicity;Any clinically significant occurrence that investigators and sponsor agreed would place participants at undue safety risk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), Death, Adverse Events (AEs) Leading to Discontinuation of Study Drug, and DLTs in Cycle 1</measure>
    <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Highest Level of TEAEs Severity</measure>
    <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
    <description>Severity of AEs was evaluated based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), version 4.0 as follow: Grade 1 (mild); Grade 2 (moderate); Grade 3 (severe); Grade 4 (life-threatening); Grade 5 (fatal).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Meaningful Changes in Laboratory Values</measure>
    <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Meaningful Changes in Vital Signs</measure>
    <time_frame>Baseline up to Cycle 27 day 45</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Meaningful Changes in Electrocardiogram (ECG)</measure>
    <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Response Rate (ORR)</measure>
    <time_frame>Cycle 1 Day 8 up to Cycle 27 Day 1 or disease progression or death</time_frame>
    <description>The estimate of the ORR is calculated as crude percentage of participants who's best overall response is complete response (CR) or partial response (PR). Objective response (CR and PR) as determined by the participants best tumor response was assessed using response evaluation criteria in solid tumors (RECIST) version 1.1. As per RECIST version 1.1, CR was defined as complete disappearance of all target lesions and non-target disease, with the exception of nodal disease. All nodes, both target and non-target, must decrease to normal (short axis &lt;10 millimeter [mm]). No new lesions. PR was defined as &gt;=30% decrease under baseline of the sum of diameters of all target lesions. The short axis was used in the sum for target nodes, while the longest diameter was used in the sum for all other target lesions. No unequivocal progression of non-target disease. No new lesions. Stable disease was defined as not qualifying for CR, PR, and progressive disease (PD).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Objective Response</measure>
    <time_frame>Cycle 1 Day 8 up to Cycle 27 Day 1 or disease progression or death</time_frame>
    <description>Duration of response was to be calculated for participants who achieved CR or PR. Duration of objective response was defined as the number of days from the start date of PR or CR (whichever response was achieved first) to the first date that PD or disease progression was objectively documented. The duration of objective response was to be right-censored for participants who achieved CR or PR and met 1 of the following conditions: Non-protocol anticancer treatment started before documentation of PD; Documented PD after more than 1 missed disease assessment visit; Alive and did not have documentation of PD before a data analysis cutoff date.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Benefit Rate (CBR)</measure>
    <time_frame>Cycle 1 Day 8 up to Cycle 27 Day 1 or disease progression or death</time_frame>
    <description>Clinical benefit rate was defined as the participants who achieved stable disease (SD) for at least 15 weeks, CR, or PR. The estimate of the CBR was calculated as crude percentage of participants whose best ORR was CR, PR or SD for at least 90 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax: Maximum Observed Plasma Concentration for TAK-117</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ctrough: Observed Concentration at the End of Dosing Interval for TAK-117</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for TAK-117</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T 1/2z: Terminal Disposition Phase Half-life for TAK-117</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUCâˆž: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity for TAK-117</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-117</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>%AUC Extrapolated: Percentage of Area Under Concentration-extrapolated</measure>
    <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Change From Baseline in Pharmacodynamic Markers</measure>
    <time_frame>Cycle 1 Day 8</time_frame>
    <description>Pharmacodynamic markers included phosphorylated ribosomal protein S6 (PS6), phosphorylated eukaryotic initiation factor 4E-binding protein 1 (P4EBP1), phosphorylated N-myc downstream regulated gene 1 (PNDRG1), phosphorylated proline-rich AKT substrate of 40 kilodaltons (PPRAS40), and phosphorylated serine/threonine protein kinase AKT (PAKT). Analysis population (n) for each skin biopsy biomarker is as follow: P4EBP1 (n=6,6,6,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PAKT and PNDRG1 (n=6,6,7,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PPRAS40 (n= 6,0,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PS6 (n=6,6,7,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0).&quot;n&quot; for each tumor tissue biomarkers is as follow: P4EBP1, PAKT, PNDRG1, and PS6 (n=1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PPRAS40 (n= 1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Metastatic Solid Tumors</condition>
  <arm_group>
    <arm_group_label>Arm A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAK-117 administered once a day orally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAK-117 administered orally intermittently, once every other day (Monday, Wednesday, and Friday) each week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAK-117 administered orally intermittently, once a day for 3 consecutive days (Monday, Tuesday, and Wednesday) each week</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TAK-117</intervention_name>
    <description>oral administration of TAK-117, daily and intermittent schedules.</description>
    <arm_group_label>Arm A</arm_group_label>
    <arm_group_label>Arm B</arm_group_label>
    <arm_group_label>Arm C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects have had their PIK3CA gene mutation status assessed prior to enrolling into
             the study

          -  Subjects must have documented disease progression prior to enrolling into the study

          -  locally advanced or metastatic solid tumors with the exception of primary brain tumor,
             and have failed or are not eligible for standard of care therapy.

          -  Age greater than or equal to (&gt;=) 18 years, including males and females;

          -  Eastern cooperative oncology group (ECOG) performance status (PS) 0-1;

          -  Adequate organ function;

          -  Male subjects must be surgically sterile or must agree to use physician-approved
             contraception during the study and for 30 days following the last study drug
             administration;

          -  Ability to swallow oral medications;

          -  Ability to understand and willingness to sign informed consent prior to initiation of
             any study procedures;

          -  For women of child-bearing potential, negative serum pregnancy test within 14 days
             prior to the first study drug administration and use of physician-approved method of
             birth control from 30 days prior to the first study drug administration to 30 days
             following the last study drug administration

        Exclusion Criteria:

          -  Diagnosis of primary brain tumor; untreated brain metastasis or history of
             leptomeningeal disease or spinal cord compression;

          -  Received prior cancer or other investigational therapy within 2 weeks prior to the
             first administration of study drug;

          -  Have received a systemic corticosteroid within one week prior to the first
             administration of study drug;

          -  Clinically significant cardiac disease;

          -  Myocardial infarction or unstable angina within 6 months prior to the first
             administration of study drug;

          -  Malabsorption ;

          -  Poorly controlled diabetes mellitus;

          -  Pregnancy (positive serum or urine pregnancy test) or breast feeding;

          -  Untreated brain metastasis or history of leptomeningeal disease or spinal cord
             compression;

          -  Failed to recover from the reversible effects of prior anticancer therapies;

          -  Have received a selective phosphoinositide-3-kinase alpha isoform (PI3K-alpha)
             inhibitor

          -  Other clinically significant co-morbidities, such as uncontrolled pulmonary disease,
             active central nervous system (CNS) disease, active infection, or any other condition
             that could compromise the subject's participation in the study

          -  Known human immunodeficiency virus (HIV) infection

          -  Have a secondary malignancy within the last 3 years prior to first dose of study drug,
             excluding treated non-melanoma skin cancer, carcinoma in situ, or locally-treated
             prostate cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Millennium Pharmaceuticals, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sutton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2011</study_first_submitted>
  <study_first_submitted_qc>October 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2011</study_first_posted>
  <results_first_submitted>January 13, 2017</results_first_submitted>
  <results_first_submitted_qc>January 13, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 9, 2017</results_first_posted>
  <last_update_submitted>January 13, 2017</last_update_submitted>
  <last_update_submitted_qc>January 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>INK1117</keyword>
  <keyword>PIK3CA</keyword>
  <keyword>KINASE</keyword>
  <keyword>TUMOR</keyword>
  <keyword>CANCER</keyword>
  <keyword>Locally advanced or metastatic solid tumors</keyword>
  <keyword>not eligible for standard of care therapy</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants took part in the study at 5 investigative sites in England, Spain and the United States from 06 October 2011 to 15 January 2016.</recruitment_details>
      <pre_assignment_details>Participants with advanced solid tumors were enrolled in dose escalation phase to receive TAK-117(MLN1117) in 1 of 4 treatment regimen.Study originally used clinical trial material(CTM) in Process A and new CTM in Process B. Due to limited single-agent TAK-117 activity in dose escalation phase,Study was terminated before start of planned expansion.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
          <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="P2">
          <title>Process A: TAK-117 150 mg, QD</title>
          <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="P3">
          <title>Process A: TAK-117 200 mg, QD</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="P4">
          <title>Process A: TAK-117 300 mg, QD</title>
          <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="P5">
          <title>Process A: TAK-117 200 mg, MWF QW</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P6">
          <title>Process A: TAK-117 300 mg, MWF QW</title>
          <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P7">
          <title>Process A: TAK-117 400 mg, MWF QW</title>
          <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P8">
          <title>Process A: TAK-117 600 mg, MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P9">
          <title>Process A: TAK-117 900 mg, MWF QW</title>
          <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P10">
          <title>Process A: TAK-117 1200 mg, MWF QW</title>
          <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P11">
          <title>Process A: TAK-117 200 mg, MTW QW</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P12">
          <title>Process A: TAK-117 400 mg, MTW QW</title>
          <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P13">
          <title>Process A: TAK-117 600 mg, MTW QW</title>
          <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P14">
          <title>Process A: TAK-117 900 mg, MTW QW</title>
          <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="P15">
          <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P16">
          <title>Process B: TAK-117 900 mg FM MWF QW</title>
          <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P17">
          <title>Process B: TAK-117 1200 mg FM MWF QW</title>
          <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P18">
          <title>Process B: TAK-117 600 mg FM MTW QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P19">
          <title>Process B: TAK-117 900 mg FM MTW QW</title>
          <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P20">
          <title>Process B: TAK-117 1200 mg FM MTW QW</title>
          <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P21">
          <title>Process B: TAK-117 1500 mg FM MTW QW</title>
          <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P22">
          <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
          <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P23">
          <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
          <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P24">
          <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
          <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="P25">
          <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="12"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="3"/>
                <participants group_id="P14" count="11"/>
                <participants group_id="P15" count="3"/>
                <participants group_id="P16" count="3"/>
                <participants group_id="P17" count="7"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="3"/>
                <participants group_id="P21" count="6"/>
                <participants group_id="P22" count="4"/>
                <participants group_id="P23" count="4"/>
                <participants group_id="P24" count="10"/>
                <participants group_id="P25" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="12"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="3"/>
                <participants group_id="P14" count="11"/>
                <participants group_id="P15" count="3"/>
                <participants group_id="P16" count="3"/>
                <participants group_id="P17" count="7"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="3"/>
                <participants group_id="P20" count="3"/>
                <participants group_id="P21" count="6"/>
                <participants group_id="P22" count="4"/>
                <participants group_id="P23" count="4"/>
                <participants group_id="P24" count="10"/>
                <participants group_id="P25" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Disease Progression</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="9"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="3"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="8"/>
                <participants group_id="P15" count="3"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="4"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="2"/>
                <participants group_id="P21" count="5"/>
                <participants group_id="P22" count="2"/>
                <participants group_id="P23" count="3"/>
                <participants group_id="P24" count="7"/>
                <participants group_id="P25" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="2"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="1"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="1"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="1"/>
                <participants group_id="P25" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Participant Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="3"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="1"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="1"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="1"/>
                <participants group_id="P24" count="1"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Medication Prohibited by Protocol</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="1"/>
                <participants group_id="P25" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
                <participants group_id="P21" count="0"/>
                <participants group_id="P22" count="0"/>
                <participants group_id="P23" count="0"/>
                <participants group_id="P24" count="0"/>
                <participants group_id="P25" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The all subjects as treated (ASaT) population included all enrolled participants who received at least 1 dose of TAK-117.</population>
      <group_list>
        <group group_id="B1">
          <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
          <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="B2">
          <title>Process A: TAK-117 150 mg, QD</title>
          <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="B3">
          <title>Process A: TAK-117 200 mg, QD</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="B4">
          <title>Process A: TAK-117 300 mg, QD</title>
          <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="B5">
          <title>Process A: TAK-117 200 mg, MWF QW</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B6">
          <title>Process A: TAK-117 300 mg, MWF QW</title>
          <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B7">
          <title>Process A: TAK-117 400 mg, MWF QW</title>
          <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B8">
          <title>Process A: TAK-117 600 mg, MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B9">
          <title>Process A: TAK-117 900 mg, MWF QW</title>
          <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B10">
          <title>Process A: TAK-117 1200 mg, MWF QW</title>
          <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B11">
          <title>Process A: TAK-117 200 mg, MTW QW</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B12">
          <title>Process A: TAK-117 400 mg, MTW QW</title>
          <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B13">
          <title>Process A: TAK-117 600 mg, MTW QW</title>
          <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B14">
          <title>Process A: TAK-117 900 mg, MTW QW</title>
          <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="B15">
          <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B16">
          <title>Process B: TAK-117 900 mg FM MWF QW</title>
          <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B17">
          <title>Process B: TAK-117 1200 mg FM MWF QW</title>
          <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B18">
          <title>Process B: TAK-117 600 mg FM MTW QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B19">
          <title>Process B: TAK-117 900 mg FM MTW QW</title>
          <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B20">
          <title>Process B: TAK-117 1200 mg FM MTW QW</title>
          <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B21">
          <title>Process B: TAK-117 1500 mg FM MTW QW</title>
          <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B22">
          <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
          <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B23">
          <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
          <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B24">
          <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
          <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B25">
          <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="B26">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="8"/>
            <count group_id="B4" value="4"/>
            <count group_id="B5" value="3"/>
            <count group_id="B6" value="3"/>
            <count group_id="B7" value="3"/>
            <count group_id="B8" value="3"/>
            <count group_id="B9" value="12"/>
            <count group_id="B10" value="3"/>
            <count group_id="B11" value="3"/>
            <count group_id="B12" value="3"/>
            <count group_id="B13" value="3"/>
            <count group_id="B14" value="11"/>
            <count group_id="B15" value="3"/>
            <count group_id="B16" value="3"/>
            <count group_id="B17" value="7"/>
            <count group_id="B18" value="3"/>
            <count group_id="B19" value="3"/>
            <count group_id="B20" value="3"/>
            <count group_id="B21" value="6"/>
            <count group_id="B22" value="4"/>
            <count group_id="B23" value="4"/>
            <count group_id="B24" value="10"/>
            <count group_id="B25" value="8"/>
            <count group_id="B26" value="125"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.7" spread="9.79"/>
                    <measurement group_id="B2" value="59.0" spread="10.88"/>
                    <measurement group_id="B3" value="59.3" spread="9.05"/>
                    <measurement group_id="B4" value="45.3" spread="7.27"/>
                    <measurement group_id="B5" value="56.3" spread="17.67"/>
                    <measurement group_id="B6" value="52.7" spread="14.01"/>
                    <measurement group_id="B7" value="54.3" spread="12.58"/>
                    <measurement group_id="B8" value="65.0" spread="13.11"/>
                    <measurement group_id="B9" value="56.4" spread="13.28"/>
                    <measurement group_id="B10" value="53.3" spread="19.40"/>
                    <measurement group_id="B11" value="64.7" spread="18.58"/>
                    <measurement group_id="B12" value="50.0" spread="11.53"/>
                    <measurement group_id="B13" value="55.0" spread="9.54"/>
                    <measurement group_id="B14" value="57.4" spread="10.88"/>
                    <measurement group_id="B15" value="65.7" spread="12.86"/>
                    <measurement group_id="B16" value="62.7" spread="16.17"/>
                    <measurement group_id="B17" value="61.0" spread="11.89"/>
                    <measurement group_id="B18" value="52.7" spread="19.76"/>
                    <measurement group_id="B19" value="53.7" spread="1.53"/>
                    <measurement group_id="B20" value="66.7" spread="2.52"/>
                    <measurement group_id="B21" value="61.3" spread="13.68"/>
                    <measurement group_id="B22" value="72.5" spread="4.65"/>
                    <measurement group_id="B23" value="60.3" spread="11.81"/>
                    <measurement group_id="B24" value="66.0" spread="8.71"/>
                    <measurement group_id="B25" value="59.5" spread="10.39"/>
                    <measurement group_id="B26" value="59.4" spread="11.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="9"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="7"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="5"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="2"/>
                    <measurement group_id="B21" value="4"/>
                    <measurement group_id="B22" value="4"/>
                    <measurement group_id="B23" value="4"/>
                    <measurement group_id="B24" value="5"/>
                    <measurement group_id="B25" value="6"/>
                    <measurement group_id="B26" value="84"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="5"/>
                    <measurement group_id="B25" value="2"/>
                    <measurement group_id="B26" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="1"/>
                    <measurement group_id="B26" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="3"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="11"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="11"/>
                    <measurement group_id="B15" value="3"/>
                    <measurement group_id="B16" value="3"/>
                    <measurement group_id="B17" value="7"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="3"/>
                    <measurement group_id="B21" value="6"/>
                    <measurement group_id="B22" value="4"/>
                    <measurement group_id="B23" value="4"/>
                    <measurement group_id="B24" value="9"/>
                    <measurement group_id="B25" value="7"/>
                    <measurement group_id="B26" value="117"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="12"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="3"/>
                    <measurement group_id="B14" value="11"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="7"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="3"/>
                    <measurement group_id="B20" value="3"/>
                    <measurement group_id="B21" value="6"/>
                    <measurement group_id="B22" value="3"/>
                    <measurement group_id="B23" value="3"/>
                    <measurement group_id="B24" value="10"/>
                    <measurement group_id="B25" value="8"/>
                    <measurement group_id="B26" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="1"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="0"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Female Child Bearing Potential</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Females of Child-bearing Potential</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="1"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="0"/>
                    <measurement group_id="B26" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-menopausal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="2"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="4"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="2"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="4"/>
                    <measurement group_id="B22" value="4"/>
                    <measurement group_id="B23" value="3"/>
                    <measurement group_id="B24" value="3"/>
                    <measurement group_id="B25" value="4"/>
                    <measurement group_id="B26" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sterilized Females</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="5"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="0"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="1"/>
                    <measurement group_id="B25" value="2"/>
                    <measurement group_id="B26" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Males (Excluded from this analysis)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="2"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="4"/>
                    <measurement group_id="B15" value="2"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="2"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="2"/>
                    <measurement group_id="B22" value="0"/>
                    <measurement group_id="B23" value="0"/>
                    <measurement group_id="B24" value="5"/>
                    <measurement group_id="B25" value="2"/>
                    <measurement group_id="B26" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <description>Height data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.</description>
          <units>centimeter (cm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="161.70" spread="10.758"/>
                    <measurement group_id="B2" value="164.29" spread="7.241"/>
                    <measurement group_id="B3" value="165.25" spread="9.403"/>
                    <measurement group_id="B4" value="164.15" spread="5.837"/>
                    <measurement group_id="B5" value="164.19" spread="5.195"/>
                    <measurement group_id="B6" value="161.81" spread="5.222"/>
                    <measurement group_id="B7" value="165.17" spread="7.848"/>
                    <measurement group_id="B8" value="163.49" spread="6.883"/>
                    <measurement group_id="B9" value="163.08" spread="12.871"/>
                    <measurement group_id="B10" value="158.76" spread="9.161"/>
                    <measurement group_id="B11" value="168.76" spread="2.043"/>
                    <measurement group_id="B12" value="173.43" spread="6.072"/>
                    <measurement group_id="B13" value="164.67" spread="3.055"/>
                    <measurement group_id="B14" value="167.46" spread="10.274"/>
                    <measurement group_id="B15" value="170.22" spread="1.683"/>
                    <measurement group_id="B16" value="168.93" spread="16.176"/>
                    <measurement group_id="B17" value="168.32" spread="4.243"/>
                    <measurement group_id="B18" value="169.83" spread="13.829"/>
                    <measurement group_id="B19" value="169.52" spread="8.713"/>
                    <measurement group_id="B20" value="168.11" spread="6.887"/>
                    <measurement group_id="B21" value="165.97" spread="6.472"/>
                    <measurement group_id="B22" value="159.00" spread="3.939"/>
                    <measurement group_id="B23" value="157.05" spread="3.316"/>
                    <measurement group_id="B24" value="168.79" spread="13.186"/>
                    <measurement group_id="B25" value="164.87" spread="9.638"/>
                    <measurement group_id="B26" value="165.49" spread="9.098"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <description>Weight data was available only for 123 participants as follow: n=5,6,8,4,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,10,8.</description>
          <units>kilogram (kg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.18" spread="6.403"/>
                    <measurement group_id="B2" value="71.15" spread="21.862"/>
                    <measurement group_id="B3" value="73.48" spread="9.159"/>
                    <measurement group_id="B4" value="67.65" spread="24.513"/>
                    <measurement group_id="B5" value="72.48" spread="17.665"/>
                    <measurement group_id="B6" value="61.54" spread="2.487"/>
                    <measurement group_id="B7" value="57.73" spread="0.462"/>
                    <measurement group_id="B8" value="63.41" spread="3.880"/>
                    <measurement group_id="B9" value="69.14" spread="15.486"/>
                    <measurement group_id="B10" value="65.03" spread="15.137"/>
                    <measurement group_id="B11" value="70.76" spread="16.458"/>
                    <measurement group_id="B12" value="83.39" spread="28.852"/>
                    <measurement group_id="B13" value="60.60" spread="9.016"/>
                    <measurement group_id="B14" value="73.78" spread="12.955"/>
                    <measurement group_id="B15" value="72.26" spread="11.235"/>
                    <measurement group_id="B16" value="75.22" spread="12.679"/>
                    <measurement group_id="B17" value="79.84" spread="16.648"/>
                    <measurement group_id="B18" value="81.07" spread="25.417"/>
                    <measurement group_id="B19" value="82.72" spread="17.982"/>
                    <measurement group_id="B20" value="62.61" spread="15.706"/>
                    <measurement group_id="B21" value="64.59" spread="16.477"/>
                    <measurement group_id="B22" value="73.65" spread="16.747"/>
                    <measurement group_id="B23" value="65.37" spread="11.853"/>
                    <measurement group_id="B24" value="70.51" spread="15.263"/>
                    <measurement group_id="B25" value="65.11" spread="9.599"/>
                    <measurement group_id="B26" value="70.17" spread="14.958"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Surface Area (BSA)</title>
          <description>BSA data was available only for 119 participants as follow: n=5,6,8,2,3,2,3,3,12,3,3,3,3,11,3,3,7,3,3,3,6,4,4,9,7.</description>
          <units>square meter (m^2)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.67" spread="0.108"/>
                    <measurement group_id="B2" value="1.78" spread="0.266"/>
                    <measurement group_id="B3" value="1.83" spread="0.152"/>
                    <measurement group_id="B4" value="1.85" spread="0.500"/>
                    <measurement group_id="B5" value="1.81" spread="0.241"/>
                    <measurement group_id="B6" value="1.66" spread="0.060"/>
                    <measurement group_id="B7" value="1.63" spread="0.041"/>
                    <measurement group_id="B8" value="1.70" spread="0.063"/>
                    <measurement group_id="B9" value="1.76" spread="0.248"/>
                    <measurement group_id="B10" value="1.69" spread="0.192"/>
                    <measurement group_id="B11" value="1.81" spread="0.209"/>
                    <measurement group_id="B12" value="1.99" spread="0.354"/>
                    <measurement group_id="B13" value="1.66" spread="0.110"/>
                    <measurement group_id="B14" value="1.85" spread="0.214"/>
                    <measurement group_id="B15" value="1.85" spread="0.151"/>
                    <measurement group_id="B16" value="1.88" spread="0.235"/>
                    <measurement group_id="B17" value="1.92" spread="0.210"/>
                    <measurement group_id="B18" value="1.95" spread="0.384"/>
                    <measurement group_id="B19" value="1.97" spread="0.262"/>
                    <measurement group_id="B20" value="1.70" spread="0.250"/>
                    <measurement group_id="B21" value="1.72" spread="0.253"/>
                    <measurement group_id="B22" value="1.80" spread="0.217"/>
                    <measurement group_id="B23" value="1.68" spread="0.154"/>
                    <measurement group_id="B24" value="1.82" spread="0.256"/>
                    <measurement group_id="B25" value="1.71" spread="0.170"/>
                    <measurement group_id="B26" value="1.79" spread="0.219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Maximum Tolerated Dose (MTD) of TAK-117</title>
        <description>MTD is highest dose level of TAK-117 at which no more than 1 out of 6 participants had a dose limiting toxicity (DLT) during first cycle. DLT was any 1 of following events occurring within first 21 days of Cycle 1 of TAK-117 administration, Grade 2: fasting hyperglycemia for &gt;14 days. Grade 3: nausea and/or vomiting/diarrhea for &gt;7 days; rash for &gt;7 days; thrombocytopenia with bleeding; fasting hyperglycemia for &gt;24 hours(hr). Grade &gt;=3:nonhematologic toxicity considered clinically significant by investigator. Grade 4:neutropenia (absolute neutrophil count &lt;=0.5*10^9per liter[/L]) for &gt;7 days in absence of growth factor support; neutropenia of any duration accompanied with fever &gt;=38.5 degree Celsius and/or systemic infection. Grade &gt;=4:hematologic toxicity. Inability to administer at least 75% of planned doses of TAK-117 within Cycle 1 due to its related toxicity;Any clinically significant occurrence that investigators and sponsor agreed would place participants at undue safety risk.</description>
        <time_frame>Baseline up to Cycle 1 Day 21</time_frame>
        <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: Total QD TAK-117 100-300 mg</title>
            <description>TAK-117 100-300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: Total MWF QW 200-1200 mg</title>
            <description>TAK-117 200-1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: Total MTW QW 200-900 mg</title>
            <description>TAK-117 200-900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process B: Total FM MWF QW TAK-117 600-1200 mg</title>
            <description>TAK-117 600-1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O5">
            <title>Process B: Total FM MTW QW 600-1500 mg</title>
            <description>TAK-117 600-1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O6">
            <title>Process B: Total FM BID MWF QW 300-600 mg</title>
            <description>TAK-117 300-600 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Tolerated Dose (MTD) of TAK-117</title>
          <description>MTD is highest dose level of TAK-117 at which no more than 1 out of 6 participants had a dose limiting toxicity (DLT) during first cycle. DLT was any 1 of following events occurring within first 21 days of Cycle 1 of TAK-117 administration, Grade 2: fasting hyperglycemia for &gt;14 days. Grade 3: nausea and/or vomiting/diarrhea for &gt;7 days; rash for &gt;7 days; thrombocytopenia with bleeding; fasting hyperglycemia for &gt;24 hours(hr). Grade &gt;=3:nonhematologic toxicity considered clinically significant by investigator. Grade 4:neutropenia (absolute neutrophil count &lt;=0.5*10^9per liter[/L]) for &gt;7 days in absence of growth factor support; neutropenia of any duration accompanied with fever &gt;=38.5 degree Celsius and/or systemic infection. Grade &gt;=4:hematologic toxicity. Inability to administer at least 75% of planned doses of TAK-117 within Cycle 1 due to its related toxicity;Any clinically significant occurrence that investigators and sponsor agreed would place participants at undue safety risk.</description>
          <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>mg</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="13"/>
                <count group_id="O5" value="15"/>
                <count group_id="O6" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150"/>
                    <measurement group_id="O2" value="900"/>
                    <measurement group_id="O3" value="900"/>
                    <measurement group_id="O4" value="NA">The MTD was not determined because PK data for FM showed limited increase in exposure above 900 mg.</measurement>
                    <measurement group_id="O5" value="NA">The MTD was not determined because PK data for FM showed limited increase in exposure above 900 mg.</measurement>
                    <measurement group_id="O6" value="500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), Death, Adverse Events (AEs) Leading to Discontinuation of Study Drug, and DLTs in Cycle 1</title>
        <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
        <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs), Death, Adverse Events (AEs) Leading to Discontinuation of Study Drug, and DLTs in Cycle 1</title>
          <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="11"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="7"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="6"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="4"/>
                <count group_id="O24" value="10"/>
                <count group_id="O25" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="12"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="3"/>
                    <measurement group_id="O13" value="3"/>
                    <measurement group_id="O14" value="11"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="3"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="3"/>
                    <measurement group_id="O20" value="3"/>
                    <measurement group_id="O21" value="6"/>
                    <measurement group_id="O22" value="3"/>
                    <measurement group_id="O23" value="4"/>
                    <measurement group_id="O24" value="10"/>
                    <measurement group_id="O25" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="7"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="2"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="1"/>
                    <measurement group_id="O24" value="5"/>
                    <measurement group_id="O25" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AEs leading to discontinuation of study drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="1"/>
                    <measurement group_id="O25" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="1"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DLTs in Cycle 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="1"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Highest Level of TEAEs Severity</title>
        <description>Severity of AEs was evaluated based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), version 4.0 as follow: Grade 1 (mild); Grade 2 (moderate); Grade 3 (severe); Grade 4 (life-threatening); Grade 5 (fatal).</description>
        <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
        <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Highest Level of TEAEs Severity</title>
          <description>Severity of AEs was evaluated based on National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), version 4.0 as follow: Grade 1 (mild); Grade 2 (moderate); Grade 3 (severe); Grade 4 (life-threatening); Grade 5 (fatal).</description>
          <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="11"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="7"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="6"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="4"/>
                <count group_id="O24" value="10"/>
                <count group_id="O25" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Grade 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="2"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="3"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="3"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="1"/>
                    <measurement group_id="O24" value="4"/>
                    <measurement group_id="O25" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="5"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="7"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="3"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="2"/>
                    <measurement group_id="O24" value="3"/>
                    <measurement group_id="O25" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="3"/>
                    <measurement group_id="O25" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="1"/>
                    <measurement group_id="O23" value="1"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinically Meaningful Changes in Laboratory Values</title>
        <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
        <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinically Meaningful Changes in Laboratory Values</title>
          <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="11"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="7"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="6"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="4"/>
                <count group_id="O24" value="10"/>
                <count group_id="O25" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinically Meaningful Changes in Vital Signs</title>
        <time_frame>Baseline up to Cycle 27 day 45</time_frame>
        <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinically Meaningful Changes in Vital Signs</title>
          <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="11"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="7"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="6"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="4"/>
                <count group_id="O24" value="10"/>
                <count group_id="O25" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinically Meaningful Changes in Electrocardiogram (ECG)</title>
        <time_frame>Baseline up to Cycle 27 Day 45</time_frame>
        <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinically Meaningful Changes in Electrocardiogram (ECG)</title>
          <population>The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="11"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="7"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="6"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="4"/>
                <count group_id="O24" value="10"/>
                <count group_id="O25" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                    <measurement group_id="O21" value="0"/>
                    <measurement group_id="O22" value="0"/>
                    <measurement group_id="O23" value="0"/>
                    <measurement group_id="O24" value="0"/>
                    <measurement group_id="O25" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Response Rate (ORR)</title>
        <description>The estimate of the ORR is calculated as crude percentage of participants who's best overall response is complete response (CR) or partial response (PR). Objective response (CR and PR) as determined by the participants best tumor response was assessed using response evaluation criteria in solid tumors (RECIST) version 1.1. As per RECIST version 1.1, CR was defined as complete disappearance of all target lesions and non-target disease, with the exception of nodal disease. All nodes, both target and non-target, must decrease to normal (short axis &lt;10 millimeter [mm]). No new lesions. PR was defined as &gt;=30% decrease under baseline of the sum of diameters of all target lesions. The short axis was used in the sum for target nodes, while the longest diameter was used in the sum for all other target lesions. No unequivocal progression of non-target disease. No new lesions. Stable disease was defined as not qualifying for CR, PR, and progressive disease (PD).</description>
        <time_frame>Cycle 1 Day 8 up to Cycle 27 Day 1 or disease progression or death</time_frame>
        <population>The full analysis set (FAS) population included participants who received at least 1 dose of TAK-117, baseline data for those analyses that required baseline data and postbaseline endpoint data subsequent to at least 1 dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Response Rate (ORR)</title>
          <description>The estimate of the ORR is calculated as crude percentage of participants who's best overall response is complete response (CR) or partial response (PR). Objective response (CR and PR) as determined by the participants best tumor response was assessed using response evaluation criteria in solid tumors (RECIST) version 1.1. As per RECIST version 1.1, CR was defined as complete disappearance of all target lesions and non-target disease, with the exception of nodal disease. All nodes, both target and non-target, must decrease to normal (short axis &lt;10 millimeter [mm]). No new lesions. PR was defined as &gt;=30% decrease under baseline of the sum of diameters of all target lesions. The short axis was used in the sum for target nodes, while the longest diameter was used in the sum for all other target lesions. No unequivocal progression of non-target disease. No new lesions. Stable disease was defined as not qualifying for CR, PR, and progressive disease (PD).</description>
          <population>The full analysis set (FAS) population included participants who received at least 1 dose of TAK-117, baseline data for those analyses that required baseline data and postbaseline endpoint data subsequent to at least 1 dose of study drug.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="10"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="1"/>
                <count group_id="O14" value="9"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="1"/>
                <count group_id="O17" value="5"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="2"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="5"/>
                <count group_id="O22" value="3"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="8"/>
                <count group_id="O25" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0.00" upper_limit="60.24"/>
                    <measurement group_id="O2" value="0" lower_limit="0.00" upper_limit="45.93"/>
                    <measurement group_id="O3" value="13" lower_limit="0.32" upper_limit="52.65"/>
                    <measurement group_id="O4" value="100" lower_limit="15.81" upper_limit="100.00"/>
                    <measurement group_id="O5" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O6" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O7" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O8" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O9" value="0" lower_limit="0.00" upper_limit="30.85"/>
                    <measurement group_id="O10" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O11" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O12" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O13" value="0" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O14" value="0" lower_limit="0.00" upper_limit="33.63"/>
                    <measurement group_id="O15" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O16" value="0" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O17" value="0" lower_limit="0.00" upper_limit="52.18"/>
                    <measurement group_id="O18" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O19" value="0" lower_limit="0.00" upper_limit="84.19"/>
                    <measurement group_id="O20" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O21" value="0" lower_limit="0.00" upper_limit="52.18"/>
                    <measurement group_id="O22" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O23" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O24" value="0" lower_limit="0.00" upper_limit="36.94"/>
                    <measurement group_id="O25" value="25" lower_limit="0.63" upper_limit="80.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Objective Response</title>
        <description>Duration of response was to be calculated for participants who achieved CR or PR. Duration of objective response was defined as the number of days from the start date of PR or CR (whichever response was achieved first) to the first date that PD or disease progression was objectively documented. The duration of objective response was to be right-censored for participants who achieved CR or PR and met 1 of the following conditions: Non-protocol anticancer treatment started before documentation of PD; Documented PD after more than 1 missed disease assessment visit; Alive and did not have documentation of PD before a data analysis cutoff date.</description>
        <time_frame>Cycle 1 Day 8 up to Cycle 27 Day 1 or disease progression or death</time_frame>
        <population>The duration of objective response analysis was not performed due to change in planned analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Objective Response</title>
          <description>Duration of response was to be calculated for participants who achieved CR or PR. Duration of objective response was defined as the number of days from the start date of PR or CR (whichever response was achieved first) to the first date that PD or disease progression was objectively documented. The duration of objective response was to be right-censored for participants who achieved CR or PR and met 1 of the following conditions: Non-protocol anticancer treatment started before documentation of PD; Documented PD after more than 1 missed disease assessment visit; Alive and did not have documentation of PD before a data analysis cutoff date.</description>
          <population>The duration of objective response analysis was not performed due to change in planned analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="0"/>
                <count group_id="O22" value="0"/>
                <count group_id="O23" value="0"/>
                <count group_id="O24" value="0"/>
                <count group_id="O25" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Benefit Rate (CBR)</title>
        <description>Clinical benefit rate was defined as the participants who achieved stable disease (SD) for at least 15 weeks, CR, or PR. The estimate of the CBR was calculated as crude percentage of participants whose best ORR was CR, PR or SD for at least 90 days.</description>
        <time_frame>Cycle 1 Day 8 up to Cycle 27 Day 1 or disease progression or death</time_frame>
        <population>The FAS population included participants who received at least 1 dose of TAK-117, baseline data for those analyses that required baseline data and postbaseline endpoint data subsequent to at least 1 dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Benefit Rate (CBR)</title>
          <description>Clinical benefit rate was defined as the participants who achieved stable disease (SD) for at least 15 weeks, CR, or PR. The estimate of the CBR was calculated as crude percentage of participants whose best ORR was CR, PR or SD for at least 90 days.</description>
          <population>The FAS population included participants who received at least 1 dose of TAK-117, baseline data for those analyses that required baseline data and postbaseline endpoint data subsequent to at least 1 dose of study drug.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="2"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="10"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="1"/>
                <count group_id="O14" value="9"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="1"/>
                <count group_id="O17" value="5"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="2"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="5"/>
                <count group_id="O22" value="3"/>
                <count group_id="O23" value="3"/>
                <count group_id="O24" value="8"/>
                <count group_id="O25" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="0.63" upper_limit="80.59"/>
                    <measurement group_id="O2" value="17" lower_limit="0.42" upper_limit="64.12"/>
                    <measurement group_id="O3" value="38" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O4" value="100" lower_limit="15.81" upper_limit="100.00"/>
                    <measurement group_id="O5" value="33" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O6" value="33" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O7" value="33" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O8" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O9" value="20" lower_limit="2.52" upper_limit="55.61"/>
                    <measurement group_id="O10" value="67" lower_limit="9.43" upper_limit="99.16"/>
                    <measurement group_id="O11" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O12" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O13" value="0" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O14" value="56" lower_limit="21.20" upper_limit="86.30"/>
                    <measurement group_id="O15" value="33" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O16" value="0" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O17" value="0" lower_limit="0.00" upper_limit="52.18"/>
                    <measurement group_id="O18" value="33" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O19" value="0" lower_limit="0.00" upper_limit="84.19"/>
                    <measurement group_id="O20" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O21" value="0" lower_limit="0.00" upper_limit="52.18"/>
                    <measurement group_id="O22" value="0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O23" value="33" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O24" value="25" lower_limit="3.19" upper_limit="65.09"/>
                    <measurement group_id="O25" value="25" lower_limit="0.63" upper_limit="80.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax: Maximum Observed Plasma Concentration for TAK-117</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>Pharmacokinetic (PK) population included all participants who took at least 1 dose of study drug and had sufficient plasma concentration-time data to calculate PK parameters.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 mg</title>
            <description>Cohort 1: TAK-117 100 mg, capsules, orally, once a day (QD), continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg</title>
            <description>Cohort 2: TAK-117 150 mg, capsules, orally, QD, continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg</title>
            <description>Cohort 3: TAK-117 200 mg, capsules, orally, QD, continuously; Cohort 5: TAK-117 200 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 11: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in all 3 cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg</title>
            <description>Cohort 4: TAK-117 300 mg, capsules, orally, QD, continuously; Cohort 6: TAK-117 300 mg, capsules, orally, intermittently, once every other day on MWF QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 400 mg</title>
            <description>Cohort 7: TAK-117 400 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 12: TAK-117 400 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 600 mg</title>
            <description>Cohort 8: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 13: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 900 mg</title>
            <description>Cohort 9: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 14: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 1200 mg</title>
            <description>Cohort 10: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O9">
            <title>Process B: TAK-117 300 mg</title>
            <description>Cohort 22: TAK-117 300 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O10">
            <title>Process B: TAK-117 400 mg</title>
            <description>Cohort 23: TAK-117 400 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O11">
            <title>Process B: TAK-117 500 mg</title>
            <description>Cohort 24: TAK-117 500 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O12">
            <title>Process B: TAK-117 600 mg</title>
            <description>Cohort 15: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 18: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW; Cohort 25: TAK-117 600 mg, capsules, orally, intermittently, BID every other day on MWF QW. TAK-117 was administered in all the 3 cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O13">
            <title>Process B: TAK-117 900 mg</title>
            <description>Cohort 16: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 19: TAK-117 900 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O14">
            <title>Process B: TAK-117 1200 mg</title>
            <description>Cohort 17: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW ; Cohort 20: TAK-117 1200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 1500 mg</title>
            <description>Cohort 21: TAK-117 1500 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax: Maximum Observed Plasma Concentration for TAK-117</title>
          <population>Pharmacokinetic (PK) population included all participants who took at least 1 dose of study drug and had sufficient plasma concentration-time data to calculate PK parameters.</population>
          <units>nanogram per milliliter (ng/mL)</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="4"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="14"/>
                <count group_id="O13" value="6"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1747.61" spread="48.7" lower_limit="0.63" upper_limit="80.59"/>
                    <measurement group_id="O2" value="1613.23" spread="58.5" lower_limit="0.42" upper_limit="64.12"/>
                    <measurement group_id="O3" value="2736.60" spread="36.4" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O4" value="2658.23" spread="90.0" lower_limit="15.81" upper_limit="100.00"/>
                    <measurement group_id="O5" value="4335.88" spread="42.5" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O6" value="4175.13" spread="82.4" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O7" value="7863.36" spread="42.1" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O8" value="8586.50" spread="53.6" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O9" value="1162.06" spread="117.5" lower_limit="2.52" upper_limit="55.61"/>
                    <measurement group_id="O10" value="1656.71" spread="77.0" lower_limit="9.43" upper_limit="99.16"/>
                    <measurement group_id="O11" value="2973.26" spread="53.3" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O12" value="3870.43" spread="61.1" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O13" value="6960.06" spread="69.3" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O14" value="6073.55" spread="53.2" lower_limit="21.20" upper_limit="86.30"/>
                    <measurement group_id="O15" value="6899.80" spread="67.9" lower_limit="0.84" upper_limit="90.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ctrough: Observed Concentration at the End of Dosing Interval for TAK-117</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 mg</title>
            <description>Cohort 1: TAK-117 100 mg, capsules, orally, once a day (QD), continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg</title>
            <description>Cohort 2: TAK-117 150 mg, capsules, orally, QD, continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg</title>
            <description>Cohort 3: TAK-117 200 mg, capsules, orally, QD, continuously; Cohort 5: TAK-117 200 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 11: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in all 3 cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg</title>
            <description>Cohort 4: TAK-117 300 mg, capsules, orally, QD, continuously; Cohort 6: TAK-117 300 mg, capsules, orally, intermittently, once every other day on MWF QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 400 mg</title>
            <description>Cohort 7: TAK-117 400 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 12: TAK-117 400 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 600 mg</title>
            <description>Cohort 8: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 13: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 900 mg</title>
            <description>Cohort 9: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 14: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 1200 mg</title>
            <description>Cohort 10: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O9">
            <title>Process B: TAK-117 300 mg</title>
            <description>Cohort 22: TAK-117 300 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O10">
            <title>Process B: TAK-117 400 mg</title>
            <description>Cohort 23: TAK-117 400 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O11">
            <title>Process B: TAK-117 500 mg</title>
            <description>Cohort 24: TAK-117 500 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O12">
            <title>Process B: TAK-117 600 mg</title>
            <description>Cohort 15: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 18: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW; Cohort 25: TAK-117 600 mg, capsules, orally, intermittently, BID every other day on MWF QW. TAK-117 was administered in all the 3 cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O13">
            <title>Process B: TAK-117 900 mg</title>
            <description>Cohort 16: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 19: TAK-117 900 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O14">
            <title>Process B: TAK-117 1200 mg</title>
            <description>Cohort 17: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW ; Cohort 20: TAK-117 1200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 1500 mg</title>
            <description>Cohort 21: TAK-117 1500 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Ctrough: Observed Concentration at the End of Dosing Interval for TAK-117</title>
          <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="4"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="14"/>
                <count group_id="O13" value="6"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="187.29" spread="102.1" lower_limit="0.63" upper_limit="80.59"/>
                    <measurement group_id="O2" value="177.70" spread="124.0" lower_limit="0.42" upper_limit="64.12"/>
                    <measurement group_id="O3" value="630.82" spread="70.0" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O4" value="627.62" spread="93.7" lower_limit="15.81" upper_limit="100.00"/>
                    <measurement group_id="O5" value="NA" lower_limit="0.84" upper_limit="90.57">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O6" value="NA" lower_limit="0.84" upper_limit="90.57">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O7" value="NA" lower_limit="0.84" upper_limit="90.57">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O8" value="NA" lower_limit="0.00" upper_limit="70.76">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O9" value="NA" lower_limit="2.52" upper_limit="55.61">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O10" value="NA" lower_limit="9.43" upper_limit="99.16">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O11" value="NA" lower_limit="0.00" upper_limit="70.76">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O12" value="NA" lower_limit="0.00" upper_limit="70.76">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O13" value="NA" lower_limit="0.00" upper_limit="97.50">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O14" value="NA" lower_limit="21.20" upper_limit="86.30">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O15" value="NA" lower_limit="0.84" upper_limit="90.57">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for TAK-117</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 mg</title>
            <description>Cohort 1: TAK-117 100 mg, capsules, orally, once a day (QD), continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg</title>
            <description>Cohort 2: TAK-117 150 mg, capsules, orally, QD, continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg</title>
            <description>Cohort 3: TAK-117 200 mg, capsules, orally, QD, continuously; Cohort 5: TAK-117 200 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 11: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in all 3 cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg</title>
            <description>Cohort 4: TAK-117 300 mg, capsules, orally, QD, continuously; Cohort 6: TAK-117 300 mg, capsules, orally, intermittently, once every other day on MWF QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 400 mg</title>
            <description>Cohort 7: TAK-117 400 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 12: TAK-117 400 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 600 mg</title>
            <description>Cohort 8: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 13: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 900 mg</title>
            <description>Cohort 9: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 14: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 1200 mg</title>
            <description>Cohort 10: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O9">
            <title>Process B: TAK-117 300 mg</title>
            <description>Cohort 22: TAK-117 300 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O10">
            <title>Process B: TAK-117 400 mg</title>
            <description>Cohort 23: TAK-117 400 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O11">
            <title>Process B: TAK-117 500 mg</title>
            <description>Cohort 24: TAK-117 500 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O12">
            <title>Process B: TAK-117 600 mg</title>
            <description>Cohort 15: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 18: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW; Cohort 25: TAK-117 600 mg, capsules, orally, intermittently, BID every other day on MWF QW. TAK-117 was administered in all the 3 cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O13">
            <title>Process B: TAK-117 900 mg</title>
            <description>Cohort 16: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 19: TAK-117 900 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O14">
            <title>Process B: TAK-117 1200 mg</title>
            <description>Cohort 17: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW ; Cohort 20: TAK-117 1200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 1500 mg</title>
            <description>Cohort 21: TAK-117 1500 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax: Time to Reach the Maximum Plasma Concentration (Cmax) for TAK-117</title>
          <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
          <units>hr</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="4"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="14"/>
                <count group_id="O13" value="6"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="1.5" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O3" value="2.0" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O4" value="2.1" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O5" value="4.0" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O6" value="3.1" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O7" value="2.0" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O8" value="5.8" lower_limit="4" upper_limit="8"/>
                    <measurement group_id="O9" value="1.6" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O10" value="4.0" lower_limit="2" upper_limit="8"/>
                    <measurement group_id="O11" value="3.6" lower_limit="2" upper_limit="6"/>
                    <measurement group_id="O12" value="3.4" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O13" value="4.0" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O14" value="4.0" lower_limit="1" upper_limit="23"/>
                    <measurement group_id="O15" value="3.8" lower_limit="2" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>T 1/2z: Terminal Disposition Phase Half-life for TAK-117</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 mg</title>
            <description>Cohort 1: TAK-117 100 mg, capsules, orally, once a day (QD), continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg</title>
            <description>Cohort 2: TAK-117 150 mg, capsules, orally, QD, continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg</title>
            <description>Cohort 3: TAK-117 200 mg, capsules, orally, QD, continuously; Cohort 5: TAK-117 200 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 11: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in all 3 cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg</title>
            <description>Cohort 4: TAK-117 300 mg, capsules, orally, QD, continuously; Cohort 6: TAK-117 300 mg, capsules, orally, intermittently, once every other day on MWF QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 400 mg</title>
            <description>Cohort 7: TAK-117 400 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 12: TAK-117 400 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 600 mg</title>
            <description>Cohort 8: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 13: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 900 mg</title>
            <description>Cohort 9: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 14: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 1200 mg</title>
            <description>Cohort 10: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O9">
            <title>Process B: TAK-117 300 mg</title>
            <description>Cohort 22: TAK-117 300 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O10">
            <title>Process B: TAK-117 400 mg</title>
            <description>Cohort 23: TAK-117 400 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O11">
            <title>Process B: TAK-117 500 mg</title>
            <description>Cohort 24: TAK-117 500 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O12">
            <title>Process B: TAK-117 600 mg</title>
            <description>Cohort 15: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 18: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW; Cohort 25: TAK-117 600 mg, capsules, orally, intermittently, BID every other day on MWF QW. TAK-117 was administered in all the 3 cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O13">
            <title>Process B: TAK-117 900 mg</title>
            <description>Cohort 16: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 19: TAK-117 900 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O14">
            <title>Process B: TAK-117 1200 mg</title>
            <description>Cohort 17: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW ; Cohort 20: TAK-117 1200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 1500 mg</title>
            <description>Cohort 21: TAK-117 1500 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>T 1/2z: Terminal Disposition Phase Half-life for TAK-117</title>
          <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
          <units>hrs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="4"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="14"/>
                <count group_id="O13" value="6"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.74" spread="3.0" lower_limit="0.63" upper_limit="80.59"/>
                    <measurement group_id="O2" value="7.32" spread="3.3" lower_limit="0.42" upper_limit="64.12"/>
                    <measurement group_id="O3" value="11.17" spread="4.5" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O4" value="9.75" spread="5.5" lower_limit="15.81" upper_limit="100.00"/>
                    <measurement group_id="O5" value="12.24" spread="3.9" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O6" value="14.71" spread="6.4" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O7" value="11.12" spread="3.9" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O8" value="25.87" spread="22.7" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O9" value="NA" lower_limit="2.52" upper_limit="55.61">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O10" value="NA" lower_limit="9.43" upper_limit="99.16">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O11" value="NA" lower_limit="0.00" upper_limit="70.76">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O12" value="12.17" spread="4.0" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O13" value="8.34" spread="4.7" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O14" value="14.28" spread="3.5" lower_limit="21.20" upper_limit="86.30"/>
                    <measurement group_id="O15" value="9.53" spread="2.5" lower_limit="0.84" upper_limit="90.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUCâˆž: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity for TAK-117</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 mg</title>
            <description>Cohort 1: TAK-117 100 mg, capsules, orally, once a day (QD), continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg</title>
            <description>Cohort 2: TAK-117 150 mg, capsules, orally, QD, continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg</title>
            <description>Cohort 3: TAK-117 200 mg, capsules, orally, QD, continuously; Cohort 5: TAK-117 200 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 11: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in all 3 cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg</title>
            <description>Cohort 4: TAK-117 300 mg, capsules, orally, QD, continuously; Cohort 6: TAK-117 300 mg, capsules, orally, intermittently, once every other day on MWF QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 400 mg</title>
            <description>Cohort 7: TAK-117 400 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 12: TAK-117 400 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 600 mg</title>
            <description>Cohort 8: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 13: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 900 mg</title>
            <description>Cohort 9: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 14: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 1200 mg</title>
            <description>Cohort 10: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O9">
            <title>Process B: TAK-117 300 mg</title>
            <description>Cohort 22: TAK-117 300 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O10">
            <title>Process B: TAK-117 400 mg</title>
            <description>Cohort 23: TAK-117 400 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O11">
            <title>Process B: TAK-117 500 mg</title>
            <description>Cohort 24: TAK-117 500 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O12">
            <title>Process B: TAK-117 600 mg</title>
            <description>Cohort 15: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 18: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW; Cohort 25: TAK-117 600 mg, capsules, orally, intermittently, BID every other day on MWF QW. TAK-117 was administered in all the 3 cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O13">
            <title>Process B: TAK-117 900 mg</title>
            <description>Cohort 16: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 19: TAK-117 900 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O14">
            <title>Process B: TAK-117 1200 mg</title>
            <description>Cohort 17: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW ; Cohort 20: TAK-117 1200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 1500 mg</title>
            <description>Cohort 21: TAK-117 1500 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>AUCâˆž: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity for TAK-117</title>
          <population>PK population included all participants who took at least 1 dose of study drug and had sufficient concentration-time data to calculate PK parameters.</population>
          <units>nanogram hours per milliliter (ng*hr/mL)</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="14"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="6"/>
                <count group_id="O6" value="6"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="2"/>
                <count group_id="O9" value="4"/>
                <count group_id="O10" value="4"/>
                <count group_id="O11" value="10"/>
                <count group_id="O12" value="14"/>
                <count group_id="O13" value="6"/>
                <count group_id="O14" value="10"/>
                <count group_id="O15" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18008" spread="78.8" lower_limit="0.63" upper_limit="80.59"/>
                    <measurement group_id="O2" value="13807" spread="93.2" lower_limit="0.42" upper_limit="64.12"/>
                    <measurement group_id="O3" value="44733" spread="58.0" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O4" value="42909" spread="102.2" lower_limit="15.81" upper_limit="100.00"/>
                    <measurement group_id="O5" value="93748" spread="19.8" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O6" value="75937" spread="94.4" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O7" value="129217" spread="56.0" lower_limit="0.84" upper_limit="90.57"/>
                    <measurement group_id="O8" value="309073" spread="23.7" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O9" value="NA" lower_limit="2.52" upper_limit="55.61">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O10" value="NA" lower_limit="9.43" upper_limit="99.16">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O11" value="NA" lower_limit="0.00" upper_limit="70.76">Values were not estimable since serum concentration of TAK-117 were below the limit of quantification.</measurement>
                    <measurement group_id="O12" value="62876" spread="78.4" lower_limit="0.00" upper_limit="70.76"/>
                    <measurement group_id="O13" value="84394" spread="103.1" lower_limit="0.00" upper_limit="97.50"/>
                    <measurement group_id="O14" value="164508" spread="74.9" lower_limit="21.20" upper_limit="86.30"/>
                    <measurement group_id="O15" value="87515" spread="81.2" lower_limit="0.84" upper_limit="90.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-117</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>No data is reported since serum concentration of TAK-117 were below the limit of quantification.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 mg</title>
            <description>Cohort 1: TAK-117 100 mg, capsules, orally, once a day (QD), continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg</title>
            <description>Cohort 2: TAK-117 150 mg, capsules, orally, QD, continuously for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg</title>
            <description>Cohort 3: TAK-117 200 mg, capsules, orally, QD, continuously; Cohort 5: TAK-117 200 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 11: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in all 3 cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg</title>
            <description>Cohort 4: TAK-117 300 mg, capsules, orally, QD, continuously; Cohort 6: TAK-117 300 mg, capsules, orally, intermittently, once every other day on MWF QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 400 mg</title>
            <description>Cohort 7: TAK-117 400 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 12: TAK-117 400 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 600 mg</title>
            <description>Cohort 8: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 13: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 900 mg</title>
            <description>Cohort 9: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 14: TAK-117 200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 1200 mg</title>
            <description>Cohort 10: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW for first 21 days of therapy (Cycle 1). Process A included participants who received original formulation of TAK-117 capsules.</description>
          </group>
          <group group_id="O9">
            <title>Process B: TAK-117 300 mg</title>
            <description>Cohort 22: TAK-117 300 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O10">
            <title>Process B: TAK-117 400 mg</title>
            <description>Cohort 23: TAK-117 400 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O11">
            <title>Process B: TAK-117 500 mg</title>
            <description>Cohort 24: TAK-117 500 mg, capsules, orally, intermittently, BID every other day on MWF QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O12">
            <title>Process B: TAK-117 600 mg</title>
            <description>Cohort 15: TAK-117 600 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 18: TAK-117 600 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW; Cohort 25: TAK-117 600 mg, capsules, orally, intermittently, BID every other day on MWF QW. TAK-117 was administered in all the 3 cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O13">
            <title>Process B: TAK-117 900 mg</title>
            <description>Cohort 16: TAK-117 900 mg, capsules, orally, intermittently, once every other day on MWF QW; Cohort 19: TAK-117 900 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O14">
            <title>Process B: TAK-117 1200 mg</title>
            <description>Cohort 17: TAK-117 1200 mg, capsules, orally, intermittently, once every other day on MWF QW ; Cohort 20: TAK-117 1200 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW. TAK-117 was administered in both the cohorts for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 1500 mg</title>
            <description>Cohort 21: TAK-117 1500 mg, capsules, orally, intermittently, QD for 3 consecutive days, on MTW QW for first 21 days of therapy (Cycle 1). Process B in the study is referred to the study design when new CTM was introduced. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for TAK-117</title>
          <population>No data is reported since serum concentration of TAK-117 were below the limit of quantification.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>%AUC Extrapolated: Percentage of Area Under Concentration-extrapolated</title>
        <time_frame>Process A: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 24 hrs) post-dose; Process B: Cycle 1 Day 1 pre-dose and at multiple timepoints (up to 48 hrs) post-dose</time_frame>
        <population>No data is reported since serum concentration of TAK-117 were below the limit of quantification.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>%AUC Extrapolated: Percentage of Area Under Concentration-extrapolated</title>
          <population>No data is reported since serum concentration of TAK-117 were below the limit of quantification.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
                <count group_id="O7" value="0"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="0"/>
                <count group_id="O11" value="0"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="0"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
                <count group_id="O21" value="0"/>
                <count group_id="O22" value="0"/>
                <count group_id="O23" value="0"/>
                <count group_id="O24" value="0"/>
                <count group_id="O25" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Change From Baseline in Pharmacodynamic Markers</title>
        <description>Pharmacodynamic markers included phosphorylated ribosomal protein S6 (PS6), phosphorylated eukaryotic initiation factor 4E-binding protein 1 (P4EBP1), phosphorylated N-myc downstream regulated gene 1 (PNDRG1), phosphorylated proline-rich AKT substrate of 40 kilodaltons (PPRAS40), and phosphorylated serine/threonine protein kinase AKT (PAKT). Analysis population (n) for each skin biopsy biomarker is as follow: P4EBP1 (n=6,6,6,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PAKT and PNDRG1 (n=6,6,7,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PPRAS40 (n= 6,0,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PS6 (n=6,6,7,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0).&quot;n&quot; for each tumor tissue biomarkers is as follow: P4EBP1, PAKT, PNDRG1, and PS6 (n=1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PPRAS40 (n= 1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0).</description>
        <time_frame>Cycle 1 Day 8</time_frame>
        <population>Asat population where baseline and post-baseline assessments were available. The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
        <group_list>
          <group group_id="O1">
            <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
            <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O2">
            <title>Process A: TAK-117 150 mg, QD</title>
            <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O3">
            <title>Process A: TAK-117 200 mg, QD</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O4">
            <title>Process A: TAK-117 300 mg, QD</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
          </group>
          <group group_id="O5">
            <title>Process A: TAK-117 200 mg, MWF QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O6">
            <title>Process A: TAK-117 300 mg, MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O7">
            <title>Process A: TAK-117 400 mg, MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O8">
            <title>Process A: TAK-117 600 mg, MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O9">
            <title>Process A: TAK-117 900 mg, MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O10">
            <title>Process A: TAK-117 1200 mg, MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O11">
            <title>Process A: TAK-117 200 mg, MTW QW</title>
            <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O12">
            <title>Process A: TAK-117 400 mg, MTW QW</title>
            <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O13">
            <title>Process A: TAK-117 600 mg, MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O14">
            <title>Process A: TAK-117 900 mg, MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
          </group>
          <group group_id="O15">
            <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O16">
            <title>Process B: TAK-117 900 mg FM MWF QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O17">
            <title>Process B: TAK-117 1200 mg FM MWF QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O18">
            <title>Process B: TAK-117 600 mg FM MTW QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O19">
            <title>Process B: TAK-117 900 mg FM MTW QW</title>
            <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O20">
            <title>Process B: TAK-117 1200 mg FM MTW QW</title>
            <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O21">
            <title>Process B: TAK-117 1500 mg FM MTW QW</title>
            <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O22">
            <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
            <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O23">
            <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
            <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O24">
            <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
            <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
          <group group_id="O25">
            <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
            <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline in Pharmacodynamic Markers</title>
          <description>Pharmacodynamic markers included phosphorylated ribosomal protein S6 (PS6), phosphorylated eukaryotic initiation factor 4E-binding protein 1 (P4EBP1), phosphorylated N-myc downstream regulated gene 1 (PNDRG1), phosphorylated proline-rich AKT substrate of 40 kilodaltons (PPRAS40), and phosphorylated serine/threonine protein kinase AKT (PAKT). Analysis population (n) for each skin biopsy biomarker is as follow: P4EBP1 (n=6,6,6,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PAKT and PNDRG1 (n=6,6,7,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PPRAS40 (n= 6,0,6,2,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PS6 (n=6,6,7,2,2,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0).&quot;n&quot; for each tumor tissue biomarkers is as follow: P4EBP1, PAKT, PNDRG1, and PS6 (n=1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0); PPRAS40 (n= 1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0).</description>
          <population>Asat population where baseline and post-baseline assessments were available. The ASat population included all enrolled participants who received at least 1 dose of TAK-117.</population>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
                <count group_id="O3" value="8"/>
                <count group_id="O4" value="4"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="3"/>
                <count group_id="O13" value="3"/>
                <count group_id="O14" value="11"/>
                <count group_id="O15" value="3"/>
                <count group_id="O16" value="3"/>
                <count group_id="O17" value="7"/>
                <count group_id="O18" value="3"/>
                <count group_id="O19" value="3"/>
                <count group_id="O20" value="3"/>
                <count group_id="O21" value="6"/>
                <count group_id="O22" value="4"/>
                <count group_id="O23" value="4"/>
                <count group_id="O24" value="10"/>
                <count group_id="O25" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Skin Biopsy: P4EBP1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-27.94" spread="56.666"/>
                    <measurement group_id="O2" value="-13.07" spread="39.758"/>
                    <measurement group_id="O3" value="-61.41" spread="40.015"/>
                    <measurement group_id="O4" value="-24.50" spread="54.388"/>
                    <measurement group_id="O5" value="-100.00" spread="0.000"/>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="-100.00">Standard deviation could not be calculate since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O19" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O20" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O21" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O22" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O23" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O24" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O25" value="NA">None of the participants were evaluable for this category.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Biopsy: PAKT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.59" spread="33.833"/>
                    <measurement group_id="O2" value="190.32" spread="257.212"/>
                    <measurement group_id="O3" value="-30.02" spread="37.444"/>
                    <measurement group_id="O4" value="-12.97" spread="5.896"/>
                    <measurement group_id="O5" value="-18.75" spread="26.517"/>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="733.33">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O19" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O20" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O21" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O22" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O23" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O24" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O25" value="NA">None of the participants were evaluable for this category.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Biopsy: PNDRG1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-9.82" spread="15.138"/>
                    <measurement group_id="O2" value="-0.11" spread="35.915"/>
                    <measurement group_id="O3" value="-10.11" spread="26.814"/>
                    <measurement group_id="O4" value="-21.67" spread="35.355"/>
                    <measurement group_id="O5" value="10.69" spread="31.283"/>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="-34.44">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O22" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O23" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O24" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O25" value="NA">None of the participants were evaluable for this category.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Biopsy: PPRAS40</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.56" spread="272.327"/>
                    <measurement group_id="O2" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O3" value="-26.90" spread="37.191"/>
                    <measurement group_id="O4" value="-18.75" spread="61.872"/>
                    <measurement group_id="O5" value="-14.17" spread="8.250"/>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O22" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O23" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O24" value="NA">None of the participants were evaluable for this category.</measurement>
                    <measurement group_id="O25" value="NA">None of the participants were evaluable for this category.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Skin Biopsy: PS6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-15.23" spread="18.886"/>
                    <measurement group_id="O2" value="-25.05" spread="15.883"/>
                    <measurement group_id="O3" value="-11.88" spread="37.773"/>
                    <measurement group_id="O4" value="22.70" spread="24.462"/>
                    <measurement group_id="O5" value="9.54" spread="19.146"/>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="46.15">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O22" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O23" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O24" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O25" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tumor Tissue: P4EBP1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="236.00">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O2" value="-97.56">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O3" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O4" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O5" value="7.48">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O22" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O23" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O24" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O25" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tumor Tissue: PAKT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="850.00">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O2" value="-20.87">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O3" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O4" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O5" value="-44.83">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O22" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O23" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O24" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O25" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tumor Tissue: PNDRG1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134.69">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O2" value="-16.49">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O3" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O4" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O5" value="134.29">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O22" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O23" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O24" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O25" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tumor Tissue: PPRAS40</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="196.83">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O2" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O3" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O4" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O5" value="10.43">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O22" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O23" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O24" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O25" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tumor Tissue: PS6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200.00">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O2" value="0.00">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O3" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O4" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O5" value="-82.86">Standard deviation could not be calculated since only 1 participant was available for analysis.</measurement>
                    <measurement group_id="O6" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O7" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O8" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O9" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O10" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O11" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O12" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O13" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O14" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O15" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O16" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O17" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O18" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O19" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O20" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O21" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O22" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O23" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O24" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                    <measurement group_id="O25" value="NA">Data was not calculated since no participant was available for analysis.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Treatment-emergent adverse events are adverse events that started after the first dose of study drug and no more than 30 days after the last dose of study drug</time_frame>
      <desc>At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.</desc>
      <group_list>
        <group group_id="E1">
          <title>Process A: TAK-117 100 Milligram (mg), Once Daily (QD)</title>
          <description>TAK-117 100 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="E2">
          <title>Process A: TAK-117 150 mg, QD</title>
          <description>TAK-117 150 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="E3">
          <title>Process A: TAK-117 200 mg, QD</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="E4">
          <title>Process A: TAK-117 300 mg, QD</title>
          <description>TAK-117 300 mg, capsules (Process A), orally, QD up to Day 15 of each treatment cycle. Treatment cycle were repeated every 21 days.</description>
        </group>
        <group group_id="E5">
          <title>Process A: TAK-117 200 mg, MWF QW</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, once every other day on Monday, Wednesday, and Friday each week (MWF QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E6">
          <title>Process A: TAK-117 300 mg, MWF QW</title>
          <description>TAK-117 300 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E7">
          <title>Process A: TAK-117 400 mg, MWF QW</title>
          <description>TAK-117 400 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E8">
          <title>Process A: TAK-117 600 mg, MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E9">
          <title>Process A: TAK-117 900 mg, MWF QW</title>
          <description>TAK-117 900 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E10">
          <title>Process A: TAK-117 1200 mg, MWF QW</title>
          <description>TAK-117 1200 mg, capsules (Process A), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E11">
          <title>Process A: TAK-117 200 mg, MTW QW</title>
          <description>TAK-117 200 mg, capsules (Process A), orally, QD for 3 consecutive days, on Monday, Tuesday, and Wednesday each week (MTW QW) up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E12">
          <title>Process A: TAK-117 400 mg, MTW QW</title>
          <description>TAK-117 400 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E13">
          <title>Process A: TAK-117 600 mg, MTW QW</title>
          <description>TAK-117 600 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E14">
          <title>Process A: TAK-117 900 mg, MTW QW</title>
          <description>TAK-117 900 mg, capsules (Process A), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days.</description>
        </group>
        <group group_id="E15">
          <title>Process B: TAK-117 600 mg Process B Capsule (FM) MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E16">
          <title>Process B: TAK-117 900 mg FM MWF QW</title>
          <description>TAK-117 900 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E17">
          <title>Process B: TAK-117 1200 mg FM MWF QW</title>
          <description>TAK-117 1200 mg, capsules (Process B), orally, once every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E18">
          <title>Process B: TAK-117 600 mg FM MTW QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E19">
          <title>Process B: TAK-117 900 mg FM MTW QW</title>
          <description>TAK-117 900 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E20">
          <title>Process B: TAK-117 1200 mg FM MTW QW</title>
          <description>TAK-117 1200 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E21">
          <title>Process B: TAK-117 1500 mg FM MTW QW</title>
          <description>TAK-117 1500 mg, capsules (Process B), orally, QD for 3 consecutive days, on MTW QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E22">
          <title>Process B: TAK-117 300 mg FM Twice Daily (BID) MWF QW</title>
          <description>TAK-117 300 mg, capsules (Process B), orally, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E23">
          <title>Process B: TAK-117 400 mg FM BID MWF QW</title>
          <description>TAK-117 400 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E24">
          <title>Process B: TAK-117 500 mg FM BID MWF QW</title>
          <description>TAK-117 500 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
        <group group_id="E25">
          <title>Process B: TAK-117 600 mg FM BID MWF QW</title>
          <description>TAK-117 600 mg, capsules (Process B), orally, intermittently, BID every other day on MWF QW up to Day 15 of each treatment cycle. Treatment cycles were repeated every 21 days. FM used drug substance manufactured by an improved synthetic process.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (18.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="5" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Enterocutaneous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lymph node abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperosmolar state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (18.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="12" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="11" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="7" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="7" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperacusis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vitreous floaters</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Iritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="6" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="3" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="5" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="3" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Glossitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia oral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lip ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oral mucosa erosion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oral mucosal blistering</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="7" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Early satiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Catheter site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Localised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Suprapubic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Drug-induced liver injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Portal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Bacteriuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Proteus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Skin candida</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Urinary tract infection pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Back injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Incision site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Procedural site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Wound secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="3" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="4" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood lactate dehydrogenase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood urea decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood phosphorus decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Insulin C-peptide decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Protein total decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Amylase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood bicarbonate decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood fibrinogen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood thyroid stimulating hormone decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Electrocardiogram ST segment abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Electrocardiogram T wave abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Gastric pH decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lymphocyte count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>White blood cells urine positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hyperinsulinaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypoproteinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypotriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lower extremity mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign neoplasm of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Metastases to skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Parosmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>VIIth nerve paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Emotional distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vomiting psychogenic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Amenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Perineal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vaginal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rhinalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="2" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Cold sweat</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Dyshidrotic eczema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Raynaud's phenomenon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E25" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsorâ€™s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Director</name_or_title>
      <organization>Takeda</organization>
      <phone>+1-877-825-3327</phone>
      <email>trialdisclosures@takeda.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

